Biophysicists have demonstrated that Raman microscopy can be used to detect the resistance of tumour cells to cancer drugs. Unlike conventional approaches, this method does not require any antibodies or markers. It detects the response of cells to administered drugs and therefore could determine the effect of drugs in preclinical studies. The team published an article on their work in the journal Scientific Reports.
For their study, the researchers used the drugs erlotinib and osimertinib, which are available under the trade names Tarceva and Tagrisso, respectively, and have been approved for lung cancer therapy. They inhibit cell growth by binding to specific proteins on the cell surface. However, patients develop resistance to the drugs in the course of therapy, because of protein changes in cancer cells.
"In order to understand how such resistance develops, we have to be able to better analyse the drugs' mechanism of action," says the author. "Raman microscopy can help to develop better cancer drugs," adds another author. "It would be a great advantage if we could predict if a drug causes resistance in preclinical studies."
In recent years, researchers have developed novel marker-free methods of Raman spectroscopy to determine the efficacy and distribution of drugs in cancer cells. For their current study, they mutated proteins in cancer cell lines, in order to simulate protein changes that occur in patients with drug resistance.
To date, it had been challenging to conduct such experiments in vitro - i.e. in a cell culture; rather, they had to be performed with patients. "Consequently, the analysis of drug resistance can now be significantly facilitated," explains the author. Using Raman microscopy, the researchers compared the efficacy of the drugs erlotinib and osimertinib in mutated and non-mutated cells.
Raman microscopy can be used to generate a spectroscopic fingerprint of a cell's molecular composition. A comparison of the spectra before and after the drug treatment provides an indication of the chemical processes triggered by the drug.
Erlotinib and osimertinib remained ineffective in cells with mutated proteins, while the drugs showed an effect in the non-mutated cancer cells. These results match the clinical observations that patients in whom certain proteins have changed in the course of therapy no longer respond to the drugs. Accordingly, the same resistance was detected in cells that had only been observed in patients before.
In conventional tests, the efficacy of drugs is analysed indirectly using markers that are attached to the drug or its target. "Using this approach, the response of one single protein, i.e. the marker, is analysed," explains the author. "Raman microscopy, on the other hand, monitors an integral cell response; therefore, it is one of the methods that can test the efficacy of drugs in vitro."
http://news.rub.de/english/press-releases/2018-10-26-raman-microscopy-testing-cells-cancer-drug-resistance
https://www.nature.com/articles/s41598-018-33682-7
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Secret tunnels to communicate and smuggle cancer signals to their n…
Read more
Skin cancer-causing fusion gene identified
Read more
Improved photodynamic therapy to kill cancer cells
Read more
DNA in blood can track cancer development and response in real time
Read more
Cell's mechanism to cope with the loss of TCA cycle enzyme, succina…
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Regulation of Zbp1 by miR-9…
By newseditor
Posted 27 Mar
Pain-free oral delivery of…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar